Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$62 Million Settlement – Comverse Technology, Inc. Derivative Litigation
In re Comverse Technology, Inc. Derivative Litigation, No. 601272/2006 (N.Y. Sup. Ct. N.Y. Cnty.)As Co-Lead Counsel, Milberg negotiated a $62 settlement which was approved by the court in 2010. The settlement also resulted in significant corporate governance reforms, including the replacement of various directors and officers; the amendment of the company’s bylaws to permit certain shareholders to propose in the company’s proxy materials nominees for election as directors; and the requirement that all equity grants be approved by both the compensation committee and a majority of the non-employee directors. -
See More$600 Million Settlement – Lucent Technologies, Inc. Securities Litigation
In re Lucent Technologies, Inc. Securities Litigation, No. 00-621 (D.N.J.)Milberg served as Co-Lead Counsel in this securities action, which alleged that Lucent and its senior officers misrepresented the demand for Lucent products and improperly recognized hundreds of millions of dollars in revenues. The case settled for $600 million. -
See More$29.5+ Million Settlement – Dealer Management Systems Antitrust Litigation
Management Systems Antitrust Litigation, MDL 2817 (U.S. District Court for the Northern District of Illinois)Milberg is appointed Lead Counsel in this nationwide class action representing car dealerships, in which leading software providers are accused of entering into an unlawful agreement, monopolizing access to auto sales and service data in dealer management software. Milberg attorneys achieved a $29.5 million settlement against one defendant and the case is proceeding against the remaining defendant. -
See More$25 Million Settlement – U.S. ex rel. Gonzales v. J.W. Carell Enterprises, Inc.
U.S. ex rel. Gonzales v. J.W. Carell Enterprises, Inc. et al., No. 12-00389 (M.D. Tn.)Milberg represented a whistleblower or “relator” in a false claims act case against one of Tennessee’s largest home healthcare providers, which alleged the company’s fraudulent submissions of Medicare and Medicaid claims. The Government intervened and the case settled in November 2014 for $25 million and the relator’s share of the settlement was $3.9 million. -
See More$75 Million Settlement – Irvine v. ImClone Systems, Inc.
Irvine v. ImClone Systems, Inc., No. 02-0109 (S.D.N.Y.)Milberg served as Co-Lead Counsel in this case, in which the plaintiffs alleged that ImClone misrepresented the likelihood that its drug, Erbitux, would be approved, thereby artificially inflating the price of ImClone stock. The court approved a $75 million cash settlement in 2005.
